Evaluation and Correlation of Risk Recurrence in Early Breast Cancer Assessed by Oncotype DX®, Clinicopathological Markers and Tumor Cell Dissemination in the Blood and Bone Marrow

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2013.174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The ZNF217 Biomarker Predicts Low- And High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers

Frontiers in Pharmacology
Pharmacology
2019English

Tumor Cell Contamination of Peripheral Blood Stem Cell Transplants and Bone Marrow in High-Risk Breast Cancer Patients

Bone Marrow Transplantation
TransplantationHematology
1997English

Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results

SpringerPlus
Multidisciplinary
2014English

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Oncotype Dx Recurrence Score Among BRCA1/2 Germline Mutation Carriers With Hormone Receptors Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer

Breast Disease
MedicineCancer ResearchOncology
2016English

Oncotype DX Breast Cancer Recurrence Score Resists Inter-Assay Reproducibility With RT2-Profiler Multiplex RT-PCR

Scientific Reports
Multidisciplinary
2019English

Detection of Occult Tumour Cells in Bone Marrow and Blood in Breast Cancer Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1996English

Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer

JAMA Surgery
Surgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy